Clinical Trials Logo

Clinical Trial Summary

This is an open, self-paired study of 200 patients with heart failure who have a diagnosis of chronic stable angina pectoris, who will be treated for 30 days with propatyl nitrate (10mg) . Treatment regimen is 3 sublingual tablets per day, at 8:00 AM, 2:00 PM, and 8:00 PM. The study will include three visits the patient to the study center: Pretreatment / Assessment 1, Assessment 2 after 15 days of treatment, and the Assessment 3 after 30 days of treatment. At each visit, data will be collected on the medical history, physical examination and vital signs, and evaluation of episodes of angina pectoris, as well as the laboratory evaluation of adverse events and the use of concomitant medications.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02315976
Study type Interventional
Source Fundação Educacional Serra dos Órgãos
Contact
Status Completed
Phase Phase 4
Start date April 2014
Completion date December 2015

See also
  Status Clinical Trial Phase
Recruiting NCT03914131 - Clinical Trial Scheme of Xinnaoning Capsule Phase 4
Not yet recruiting NCT04264559 - The Heat Transport Characteristics of the Heart and Lung Meridians: A Study of CSAP Patients and Healthy Adults N/A
Recruiting NCT04041206 - A Study on the Microcirculatory Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With Stable Angina Pectoris
Recruiting NCT04041245 - A Study on the Metabolic Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With Stable Angina Pectoris
Not yet recruiting NCT04244812 - The Microcirculatory Characteristics of the Heart and Lung Meridians: A Study of CSAP Patients and Healthy Adults N/A
Recruiting NCT03789552 - Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina Phase 3